JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. These proposals included the appointment of directors, the approval of cash bonus objectives and future equity awards for the Chief Executive Officer, directors’ and officers’ insurance and the appointment of auditors. The voting results are provided below.
Help employers find you! Check out all the jobs and post your resume.
